Literature DB >> 19707891

Epigenetics in rheumatoid arthritis.

Michelle Trenkmann1, Matthias Brock, Caroline Ospelt, Steffen Gay.   

Abstract

Epigenetics is a steadily growing research area. In many human diseases, especially in cancers, but also in autoimmune diseases, epigenetic aberrations have been found. Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation and destruction of synovial joints. Even though the etiology is not yet fully understood, rheumatoid arthritis is generally considered to be caused by a combination of genetic predisposition, deregulated immunomodulation, and environmental influences. To gain a better understanding of this disease, researchers have become interested in studying epigenetic changes in rheumatoid arthritis. Here, we want to review the current knowledge on epigenetics in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19707891     DOI: 10.1007/s12016-009-8166-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  102 in total

1.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

Review 2.  RNA meets chromatin.

Authors:  Emily Bernstein; C David Allis
Journal:  Genes Dev       Date:  2005-07-15       Impact factor: 11.361

Review 3.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  B Richardson; L Scheinbart; J Strahler; L Gross; S Hanash; M Johnson
Journal:  Arthritis Rheum       Date:  1990-11

6.  Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines.

Authors:  S H Kang; H H Choi; S G Kim; H S Jong; N K Kim; S J Kim; Y J Bang
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

7.  Demethylation of CD40LG on the inactive X in T cells from women with lupus.

Authors:  Qianjin Lu; Ailing Wu; Laura Tesmer; Donna Ray; Neda Yousif; Bruce Richardson
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model.

Authors:  Y Nasu; K Nishida; S Miyazawa; T Komiyama; Y Kadota; N Abe; A Yoshida; S Hirohata; A Ohtsuka; T Ozaki
Journal:  Osteoarthritis Cartilage       Date:  2008-01-15       Impact factor: 6.576

9.  Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Authors:  Reinhart Seibl; Thomas Birchler; Susanne Loeliger; Johann Peter Hossle; Renate E Gay; Traudl Saurenmann; Beat A Michel; Reinhard A Seger; Steffen Gay; Roger P Lauener
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 10.  Small RNAs in transcriptional gene silencing and genome defence.

Authors:  Danesh Moazed
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962

View more
  23 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine.

Authors:  M C Powanda; E D Moyer
Journal:  Inflammopharmacology       Date:  2012-07-07       Impact factor: 4.473

Review 3.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

4.  Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Authors:  S B Krintel; C Dehlendorff; M L Hetland; K Hørslev-Petersen; K K Andersen; P Junker; J Pødenphant; T Ellingsen; P Ahlquist; H M Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; H C Horn; A Jørgensen; J Raun; C G Ammitzbøll; M Østergaard; K Stengaard-Pedersen; J S Johansen
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

Review 5.  An alternative approach to medical genetics based on modern evolutionary biology. Part 5: epigenetics and genomics.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-12       Impact factor: 5.344

6.  Regulation of DNA methylation in rheumatoid arthritis synoviocytes.

Authors:  Kazuhisa Nakano; David L Boyle; Gary S Firestein
Journal:  J Immunol       Date:  2012-12-31       Impact factor: 5.422

7.  Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis.

Authors:  Sung-Hoon Park; Seong-Kyu Kim; Jung-Yoon Choe; Youngho Moon; Sungwhan An; Mae Ja Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

Review 8.  Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

Authors:  William P Arend; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

9.  Functional genomics and rheumatoid arthritis: where have we been and where should we go?

Authors:  James N Jarvis; Mark Barton Frank
Journal:  Genome Med       Date:  2010-07-28       Impact factor: 11.117

Review 10.  Nociceptive related microRNAs and their role in rheumatoid arthritis.

Authors:  S Reyes-Long; J L Cortes-Altamirano; D Clavijio-Cornejo; M Gutiérrez; C Bertolazzi; C Bandala; C Pineda; A Alfaro-Rodríguez
Journal:  Mol Biol Rep       Date:  2020-08-01       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.